Solid cancers after bone marrow transplantation

New England Journal of Medicine

Volumn 336, Issue 13, 1997, Pages 897-904

  Curtis, Rochelle E ^a   Rowlings, Philip A ^b   Deeg, H Joachim ^c   Shriner, Donna A ^a   Socié, Gérard ^d   Travis, Lois B ^a   Horowitz, Mary M ^b   Witherspoon, Robert P ^c   Hoover, Robert N ^a   Sobocinski, Kathleen A ^b   Fraumeni Jr , Joseph F ^a   Boice Jr , John D ^a   Schoch, H Gary ^c   Sale, George E ^c   Storb, Rainer ^c   Travis, William D ^e   Kolb, Hans Jochem ^f   Gale, Robert Peter ^g   Passweg, Jakob R ^h  

^a NATIONAL CANCER INSTITUTE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c USA   (United States)

^d SAINT LOUIS HOSPITAL   (France)

^e ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^f UNIVERSITY OF MUNICH   (Germany)

^g Salick Health Care Inc   (United States)

^h Bone Marrow Transplant Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; ARTICLE; BONE CANCER; BONE MARROW TRANSPLANTATION; BRAIN CANCER; CANCER RISK; CHILD; CONNECTIVE TISSUE TUMOR; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; LEUKEMIA; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; MOUTH CANCER; PRIORITY JOURNAL; SOLID TUMOR; THYROID CANCER; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; AGE FACTORS; ANALYSIS OF VARIANCE; BONE MARROW TRANSPLANTATION; CHILD; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HEMATOLOGIC DISEASES; HUMANS; INCIDENCE; LEUKEMIA; MALE; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; RADIATION DOSAGE; REGRESSION ANALYSIS; RISK FACTORS; TIME FACTORS; WHOLE-BODY IRRADIATION;

EID: 9844227997     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199703273361301     Document Type: Article

References (40)

1. Kolb HJ, Bender-Götze C. Late complications after allogeneic bone marrow transplantation for leukaemia. Bone Marrow Transplant 1990;6:61-72.
2. Witherspoon RP, Fisher LD, Schoch G, et al. Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. N Engl J Med 1989;321:784-9.
3. Witherspoon RP, Deeg HJ, Storb R. Secondary malignancies after marrow transplantation for leukemia or aplastic anemia. Transplant Sci 1994;4:33-41.
4. Deeg HJ, Socié G, Schoch G, et al. Malignancies after marrow transplantation for aplastic anemia and Fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients. Blood 1996;87:386-92.
5. Lowsky R, Lipton J, Fyles G, et al. Secondary malignancies after bone marrow transplantation in adults. J Clin Oncol 1994;12:2187-92.
6. Socié G, Henry-Amar M, Bacigalupo A, et al. Malignant tumors occurring after treatment of aplastic anemia. N Engl J Med 1993;329:1152-7.
7. Bhatia S, Ramsay NKC, Steinbuch M, et al. Malignant neoplasms following bone marrow transplantation. Blood 1996;87:3633-9.
8. Lustig JP, Lugassy G, Neder A, Sigler E. Head and neck carcinoma in Fanconi's anaemia - report of a case and review of the literature. Eur J Cancer B Oral Oncol 1995;31B:68-72.
9. Filipovich AH, Mathur A, Kamat D, Shapiro RS. Primary immunodeficiencies: genetic risk factors for lymphoma. Cancer Res 1992;52:Suppl: 5465s-5467s.
10. Ries LAG, Miller BA, Hankey BF, Kosary CL, Harras A, Edward BK, eds. SEER cancer statistics review, 1973-1991: tables and graphs. Bethesda, Md.: National Cancer Institute, 1994. (NIH publication no. 94-2789.)
11. Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J, eds. Cancer incidence in five continents. Vol. 6. Lyon, France: International Agency for Research on Cancer, 1992. (IARC scientific publications no. 120.)
12. Muir C, Waterhouse J, Mack T, Powell J, Whelan S, eds. Cancer incidence in five continents. Vol. 5. Lyon, France: International Agency for Research on Cancer, 1987. (IARC scientific publications no. 88.)
13. Breslow NE, Day NE. Statistical methods in cancer research. Vol. 2. The design and analysis of cohort studies. Lyon, France: International Agency for Research on Cancer, 1987. (IARC scientific publications no. 82.)
14. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
15. Preston DL, Lubin JH, Pierce DA. Epicure user's guide. Seattle: HiroSoft, 1993.
16. Cox DR. Regression models and life-tables. J R Stat Soc [B] 1972;34: 187-220.
17. Vose JM, Kennedy BC, Bierman PJ, Kessinger A, Armitage JO. Long-term sequelae of autologous bone marrow or peripheral stem cell transplantation for lymphoid malignancies. Cancer 1992;69:784-9.
18. Kolb HJ, Guenther W, Duell T, et al. Cancer after bone marrow transplantation. Bone Marrow Transplant 1992;10:Suppl 1:135-8.
19. Witherspoon RP, Storb R, Pepe M, Longton G, Sullivan KM. Cumulative incidence of secondary solid malignant tumors in aplastic anemia patients given marrow grafts after conditioning with chemotherapy alone. Blood 1992;79:289-91.
20. Deeg HJ, Witherspoon RP. Risk factors for the development of secondary malignancies after marrow transplantation. Hematol Oncol Clin North Am 1993;7:417-29.
21. United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR). Sources and effects of ionizing radiation. New York: United Nations, 1994. (United Nations publication no. E.94.IX.11.)
22. Socié G, Henry-Amar M, Devergie A, et al. Poor clinical outcome of patients developing malignant solid tumors after bone marrow transplantation for severe aplastic anemia. Leuk Lymphoma 1992;7:419-23.
23. Thompson DE, Mabuchi K, Ron E, et al. Cancer incidence in atomic bomb survivors. II. Solid tumors, 1958-1987 Radiat Res 1994;137:Suppl: S17-S67. [Erratum, Radiat Res 1994;139:129.]
24. Ron E, Lubin JH, Shore RE, et al. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 1995;141: 259-77.
25. Tucker MA, Jones PH, Boice JD Jr, et al. Therapeutic radiation at a young age is linked to secondary thyroid cancer. Cancer Res 1991;51:2885-8.
26. Ron E, Modan B, Boice JD Jr, et al. Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med 1988;319:1033-9.
27. Neglia JP, Meadows AT, Robison LL, et al. Second neoplasms after acute lymphoblastic leukemia in childhood. N Engl J Med 1991;325:1330-6.
28. Tucker MA, D'Angio GJ, Boice JD Jr, et al. Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med 1987;317:588-93.
29. Eng C, Li FP, Abramson DH, et al. Mortality from second tumors among long-term survivors of retinoblastoma. J Natl Cancer Inst 1993;85: 1121-8.
30. Hawkins MM, Wilson LMK, Burton HS, et al. Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer. J Natl Cancer Inst 1996;88:270-8.
31. Land CE, Saku T, Hayashi Y, et al. Incidence of salivary gland tumors among atomic bomb survivors, 1950-1987: evaluation of radiation-related risk. Radiat Res 1996;146:28-36.
32. Kinlen LJ. Immunologic factors, including AIDS. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer epidemiology and prevention. 2nd ed. New York: Oxford University Press, 1996:532-45.
33. Sheil AG. Development of malignancy following renal transplantation in Australia and New Zealand. Transplant Proc 1992;24:1275-9.
34. Rabkin CS, Yellin F. Cancer incidence in a population with a high prevalence of infection with human immunodeficiency virus type 1. J Natl Cancer Inst 1994;86:1711-6.
35. Greene MH, Young TI, Clark WH Jr. Malignant melanoma in renal-transplant recipients. Lancet 1981;1:1196-9.
36. Tucker MA, Misfeldt D, Coleman CN, Clark WH Jr, Rosenberg SA. Cutaneous malignant melanoma after Hodgkin's disease. Ann Intern Med 1985;102:37-41.
37. Travis LB, Curtis RE, Boice JD Jr, Hankey BF, Fraumeni JF Jr. Second cancers following non-Hodgkin's lymphoma. Cancer 1991;67:2002-9.
38. Vittorio CC, Schiffman MH, Weinstock MA. Epidemiology of human papillomaviruses. Dermatol Clin 1995;13:561-74.
39. Hancock SL, Tucker MA, Hoppe RT. Breast cancer after treatment of Hodgkin's disease. J Natl Cancer Inst 1993;85:25-31.
40. Bhatia S, Robison LL, Oberlin O, et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 1996;334: 745-51.